ENDOGENOUS CYTOKININS IN MEDICINAL BASIDIOMYCETES MYCELIAL BIOMASS
| Autor: | O.B. Mykhaylova, I.V. Kosakivska, Nina A. Bisko, Nadiya Y Mytropolska, N. P. Vedenicheva, G. A. Al-Maali |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
medicinal mushrooms lcsh:Biotechnology Biomass mycelial biomass Endogeny Biology cytokinins 03 medical and health sciences 030104 developmental biology lcsh:TP248.13-248.65 Botany MEDICINAL MUSHROOMS MYCELIAL BIOMASS CYTOKININS ЛіКАРСЬКі ГРИБИ МіЦЕЛЯРНА БіОМАСА ЦИТОКіНіНИ ЛЕКАРСТВЕННЫЕ ГРИБЫ МИЦЕЛЯРНАЯ БИОМАССА ЦИТОКИНИНЫ Mycelium |
| Zdroj: | Biotechnologia Acta, Vol 9, Iss 1, Pp 55-63 (2016) |
| ISSN: | 2410-7751 |
| Popis: | The aim of the research was to study the cytokinins production by medicinal basidial mushrooms. Cytokinins were for the first time identified and quantified in mycelial biomass of six species ( Ganoderma lucidum, Trametes versicolor, Fomitopsis officinalis, Pleurotus nebrodensis, Grifola frondosa, Sparassis crispa ) using HPLC. Trans and cis -zeatin, zeatin riboside, zeatin-O-glucoside, isopentenyladenosine, isopentenyladenine were found but only one species ( G. lucidum, strain 1900) contained all these substances. The greatest total cytokinin quantity was detected in F. officinalis , strain 5004. S. crispa , strain 314, and F. officinalis , strain 5004, mycelial biomass was revealed to have the highest level of cytokinin riboside forms (zeatin riboside and isopentenyladenosine). The possible connection between medicinal properties of investigated basidiomycetes and of cytokinins is discussed. S. crispa , strain 314, and F. officinalis , strain 5004, are regarded as promising species for developing biotechnological techniques to produce biologically active drugs from their mycelial biomass. As one of the potential technological approaches there is proposed fungal material drying. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|